Edwards Lifesciences

By person

27 insiders · 981 transactions

7.9×

Mr. Zovighian holds 7.9 times base salary in stock. $9.43M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $87.51, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MUSSALLEM MICHAEL A

Director

—

$363.37M (296) scheduled

−$363.37M

4,042,863

0.7014%

$353.79M

+36.1%

BOBO DONALD E JR

CVP,Strategy/Corp Development

—

$118.50M (186) scheduled

−$118.50M

121,409

0.0211%

$10.62M

−40.0%

Ullem Scott B.

CVP, Chief Financial Officer

—

$75.91M (69) scheduled

−$75.91M

313,058

0.0543%

$27.40M

+20.8%

Wood Larry L

Global President TAVR & Surg

—

$75.28M (97) scheduled

−$75.28M

207,066

0.0359%

$18.12M

+22.1%

WANG HUIMIN

CVP, Japan & Intercontinental

—

$48.54M (81) scheduled

−$48.54M

99,381

0.0172%

$8.70M

−29.1%

Szyman Catherine M.

CVP, Critical Care

$1.07M (2)

$43.22M (84) scheduled

−$42.15M

81,287

0.0141%

$7.11M

+51.7%

Lemercier Jean-Luc M

CVP, EMEACLA and JAPAC

—

$22.66M (30) scheduled

−$22.66M

184,686

0.0320%

$16.16M

+38.7%

Zovighian Bernard J

CEO

$49.75K (1)

$14.21M (18) scheduled

−$14.16M

107,761

0.0187%

$9.43M

+252.5%

SELLERS ROBERT W.A.

SVP, Corporate Controller

—

$13.66M (18) scheduled

−$13.66M

37,490

0.0065%

$3.28M

−19.7%

Chopra Daveen

CVP, TMTT, Surgical & IHFM

—

$11.08M (24) scheduled

−$11.08M

43,926

0.0076%

$3.84M

+368.9%

Verguet Patrick B

CVP, Europe

—

$9.87M (11) scheduled

−$9.87M

129,137

0.0224%

$11.30M

0.0%

LINK WILLIAM J PHD

Director

—

$7.03M (8)

−$7.03M

16,071

0.0028%

$1.41M

−72.7%

GALLAHUE KIERAN

Director

$524.20K (2)

$3.84M (2) scheduled

−$3.32M

71,534

0.0124%

$6.26M

+131.0%

Marsh Martha H.

Director

—

$3.10M (1) scheduled

−$3.10M

31,880

0.0055%

$2.79M

+76.6%

STONE HEISZ LESLIE

Director

—

$2.92M (6) scheduled

−$2.92M

34,199

0.0059%

$2.99M

+166.2%

Lippis Daniel J.

CVP, TAVR

—

$1.93M (25) scheduled

−$1.93M

40,034

0.0069%

$3.50M

+116.4%

Markowitz Wayne

CVP, JAPAC

—

$1.11M (7) scheduled

−$1.11M

19,371

0.0034%

$1.70M

+8,591%

VON SCHACK WESLEY W

Director

—

$968.25K (4)

−$968.25K

9,737

0.0017%

$852.08K

−7.8%

VALERIANI NICHOLAS J

Director

$168.35K (1)

$698.75K (1) scheduled

−$530.41K

84,423

0.0146%

$7.39M

+140.0%

LORANGER STEVEN R

Director

—

$438.58K (1) scheduled

−$438.58K

8,997

0.0016%

$787.33K

—

Bruls Annette

CVP, EMEACLA

—

$237.91K (1)

−$237.91K

17,984

0.0031%

$1.57M

+122.6%

Dahl Andrew M.

SVP, Corporate Controller

—

$98.39K (2)

−$98.39K

14,615

0.0025%

$1.28M

+493.4%

Mistras Theodora

CVP, Chief Financial Officer

—

99,920

0.0173%

$8.74M

—

LAVIOLETTE PAUL A

Director

—

17,552

0.0030%

$1.54M

—

Davis Leslie C.

Director

—

9,834

0.0017%

$860.57K

—

Feinberg David T

Director

—

9,087

0.0016%

$795.20K

—

Sequeira Ramona

Director

—

6,779

0.0012%

$593.23K

—

By person

Individual transactions

What was left out